The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Intelligence Diagnostics Market Research Report 2025
Synopsis
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
The global Artificial Intelligence Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Diagnostics.
Report Scope
The Artificial Intelligence Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
General Electric (GE) Co. (GE Healthcare)
Siemens AG (Siemens Healthineers)
Aidoc Medical Ltd.
AliveCor, Inc.
Imagen Technologies, Inc.
VUNO, Inc.
IDx Technologies, Inc.
NovaSignal Corporation
Riverain Technologies, LLC
Zebra Medical Vision Ltd.
OSP Lab
Tessella
Philips
Segment by Type
Radiology
Oncology
Neurology
Cardiology
Chest & Lungs
Other Diagnosis Types
Segment by Application
Services
Software
Hardware
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
The global Artificial Intelligence Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Diagnostics.
Report Scope
The Artificial Intelligence Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
General Electric (GE) Co. (GE Healthcare)
Siemens AG (Siemens Healthineers)
Aidoc Medical Ltd.
AliveCor, Inc.
Imagen Technologies, Inc.
VUNO, Inc.
IDx Technologies, Inc.
NovaSignal Corporation
Riverain Technologies, LLC
Zebra Medical Vision Ltd.
OSP Lab
Tessella
Philips
Segment by Type
Radiology
Oncology
Neurology
Cardiology
Chest & Lungs
Other Diagnosis Types
Segment by Application
Services
Software
Hardware
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radiology
1.2.3 Oncology
1.2.4 Neurology
1.2.5 Cardiology
1.2.6 Chest & Lungs
1.2.7 Other Diagnosis Types
1.3 Market by Application
1.3.1 Global Artificial Intelligence Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Services
1.3.3 Software
1.3.4 Hardware
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Diagnostics Market Perspective (2019-2030)
2.2 Artificial Intelligence Diagnostics Growth Trends by Region
2.2.1 Global Artificial Intelligence Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence Diagnostics Market Dynamics
2.3.1 Artificial Intelligence Diagnostics Industry Trends
2.3.2 Artificial Intelligence Diagnostics Market Drivers
2.3.3 Artificial Intelligence Diagnostics Market Challenges
2.3.4 Artificial Intelligence Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Diagnostics Players by Revenue
3.1.1 Global Top Artificial Intelligence Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Diagnostics Revenue
3.4 Global Artificial Intelligence Diagnostics Market Concentration Ratio
3.4.1 Global Artificial Intelligence Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Diagnostics Revenue in 2023
3.5 Artificial Intelligence Diagnostics Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Diagnostics Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Diagnostics Breakdown Data by Type
4.1 Global Artificial Intelligence Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence Diagnostics Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence Diagnostics Breakdown Data by Application
5.1 Global Artificial Intelligence Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence Diagnostics Market Size (2019-2030)
6.2 North America Artificial Intelligence Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence Diagnostics Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Diagnostics Market Size (2019-2030)
7.2 Europe Artificial Intelligence Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence Diagnostics Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Diagnostics Market Size (2019-2030)
9.2 Latin America Artificial Intelligence Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 General Electric (GE) Co. (GE Healthcare)
11.1.1 General Electric (GE) Co. (GE Healthcare) Company Detail
11.1.2 General Electric (GE) Co. (GE Healthcare) Business Overview
11.1.3 General Electric (GE) Co. (GE Healthcare) Artificial Intelligence Diagnostics Introduction
11.1.4 General Electric (GE) Co. (GE Healthcare) Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.1.5 General Electric (GE) Co. (GE Healthcare) Recent Development
11.2 Siemens AG (Siemens Healthineers)
11.2.1 Siemens AG (Siemens Healthineers) Company Detail
11.2.2 Siemens AG (Siemens Healthineers) Business Overview
11.2.3 Siemens AG (Siemens Healthineers) Artificial Intelligence Diagnostics Introduction
11.2.4 Siemens AG (Siemens Healthineers) Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.2.5 Siemens AG (Siemens Healthineers) Recent Development
11.3 Aidoc Medical Ltd.
11.3.1 Aidoc Medical Ltd. Company Detail
11.3.2 Aidoc Medical Ltd. Business Overview
11.3.3 Aidoc Medical Ltd. Artificial Intelligence Diagnostics Introduction
11.3.4 Aidoc Medical Ltd. Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.3.5 Aidoc Medical Ltd. Recent Development
11.4 AliveCor, Inc.
11.4.1 AliveCor, Inc. Company Detail
11.4.2 AliveCor, Inc. Business Overview
11.4.3 AliveCor, Inc. Artificial Intelligence Diagnostics Introduction
11.4.4 AliveCor, Inc. Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.4.5 AliveCor, Inc. Recent Development
11.5 Imagen Technologies, Inc.
11.5.1 Imagen Technologies, Inc. Company Detail
11.5.2 Imagen Technologies, Inc. Business Overview
11.5.3 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Introduction
11.5.4 Imagen Technologies, Inc. Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.5.5 Imagen Technologies, Inc. Recent Development
11.6 VUNO, Inc.
11.6.1 VUNO, Inc. Company Detail
11.6.2 VUNO, Inc. Business Overview
11.6.3 VUNO, Inc. Artificial Intelligence Diagnostics Introduction
11.6.4 VUNO, Inc. Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.6.5 VUNO, Inc. Recent Development
11.7 IDx Technologies, Inc.
11.7.1 IDx Technologies, Inc. Company Detail
11.7.2 IDx Technologies, Inc. Business Overview
11.7.3 IDx Technologies, Inc. Artificial Intelligence Diagnostics Introduction
11.7.4 IDx Technologies, Inc. Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.7.5 IDx Technologies, Inc. Recent Development
11.8 NovaSignal Corporation
11.8.1 NovaSignal Corporation Company Detail
11.8.2 NovaSignal Corporation Business Overview
11.8.3 NovaSignal Corporation Artificial Intelligence Diagnostics Introduction
11.8.4 NovaSignal Corporation Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.8.5 NovaSignal Corporation Recent Development
11.9 Riverain Technologies, LLC
11.9.1 Riverain Technologies, LLC Company Detail
11.9.2 Riverain Technologies, LLC Business Overview
11.9.3 Riverain Technologies, LLC Artificial Intelligence Diagnostics Introduction
11.9.4 Riverain Technologies, LLC Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.9.5 Riverain Technologies, LLC Recent Development
11.10 Zebra Medical Vision Ltd.
11.10.1 Zebra Medical Vision Ltd. Company Detail
11.10.2 Zebra Medical Vision Ltd. Business Overview
11.10.3 Zebra Medical Vision Ltd. Artificial Intelligence Diagnostics Introduction
11.10.4 Zebra Medical Vision Ltd. Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.10.5 Zebra Medical Vision Ltd. Recent Development
11.11 OSP Lab
11.11.1 OSP Lab Company Detail
11.11.2 OSP Lab Business Overview
11.11.3 OSP Lab Artificial Intelligence Diagnostics Introduction
11.11.4 OSP Lab Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.11.5 OSP Lab Recent Development
11.12 Tessella
11.12.1 Tessella Company Detail
11.12.2 Tessella Business Overview
11.12.3 Tessella Artificial Intelligence Diagnostics Introduction
11.12.4 Tessella Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.12.5 Tessella Recent Development
11.13 Philips
11.13.1 Philips Company Detail
11.13.2 Philips Business Overview
11.13.3 Philips Artificial Intelligence Diagnostics Introduction
11.13.4 Philips Revenue in Artificial Intelligence Diagnostics Business (2019-2024)
11.13.5 Philips Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
